Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats

References

• Aghasafari P, George U, Pidaparti R. (2019). A review of inflammatory mechanism in airway diseases. Inflamm Res 68: 59–74.
   PubMed Web of Science ®Google Scholar
• Alanazi A, Fadda L, Alhusaini A, Ahmad R. (2020). Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats. J Biochem Mol Toxicol 34: e22492.
   PubMed Web of Science ®Google Scholar
• Amara RO, Ramadan AA, El-Moslemany RM, et al. (2018). Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting. Int J Nanomedicine 13:4493–505.
   PubMed Web of Science ®Google Scholar
• Ashafaq M, Intakhab Alam M, Khan A, et al. (2021). Nanoparticles of resveratrol attenuates oxidative stress and inflammation after ischemic stroke in rats. Int Immunopharmacol 94:107494.
   PubMed Web of Science ®Google Scholar
• Ashour AA, Ramadan AA, Abdelmonsif DA, El-Kamel AH. (2020). Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: formulation, in-vitro appraisal and pharmacokinetics. Int J Pharm 586:119598.
   PubMedGoogle Scholar
• Attama AA, Momoh MA, Builders PF. (2012). Lipid nanoparticulate drug delivery systems. In: A revolution in dosage form design and development. China: Intech Open Access Publisher.
   Google Scholar
• Azmoonfar R, Amini P, Yahyapour R, et al. (2020). Mitigation of radiation-induced pneumonitis and lung fibrosis using alpha-lipoic acid and resveratrol. Antiinflamm Antiallergy Agents Med Chem 19: 149–57.
   PubMedGoogle Scholar
• Baek AR, Hong J, Song KS, et al. (2020). Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice. Exp Mol Med 52: 2034–45.
   PubMed Web of Science ®Google Scholar
• Bian S, Cai H, Cui Y, et al. (2021). Nanomedicine-based therapeutics to combat acute lung injury. Int J Nanomedicine 16:2247–69.
   PubMed Web of Science ®Google Scholar
• Cheng P, Li S, Chen H. (2021). Macrophages in lung injury, repair, and fibrosis. Cells 10:436.
   PubMed Web of Science ®Google Scholar
• Cheresh P, Kim SJ, Jablonski R, et al. (2021). SIRT3 overexpression ameliorates asbestos-induced pulmonary fibrosis, mt-DNA damage, and lung fibrogenic monocyte recruitment. IJMS 22: 6856.
   Google Scholar
• Conte E, Fagone E, Fruciano M, et al. (2015). Anti-inflammatory and antifibrotic effects of resveratrol in the lung. Histol Histopathol 30: 523–9.
   PubMed Web of Science ®Google Scholar
• de Oliveira MTP, Coutinho DS, Guterres SS, et al. (2021). Resveratrol-loaded lipid-core nanocapsules modulate acute lung inflammation and oxidative imbalance induced by LPS in mice. Pharmaceutics 13: 683.
   PubMed Web of Science ®Google Scholar
• de Oliveira MTP, de Sá Coutinho D, Tenório de Souza É, et al. (2019). Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways. Int J Nanomed 14:5215–28.
   PubMed Web of Science ®Google Scholar
• Deng C, Zhai Z, Wu D, et al. (2015). Inflammatory response and pneumocyte apoptosis during lung ischemia-reperfusion injury in an experimental pulmonary thromboembolism model. J Thromb Thrombolysis 40: 42–53.
   PubMed Web of Science ®Google Scholar
• Dikmen N, Cellat M, Etyemez M, et al. (2021). Ameliorative effects of oleuropein on lipopolysaccharide-induced acute lung injury model in rats. Inflammation 44: 2246–59.
   PubMed Web of Science ®Google Scholar
• Ding S, Wang H, Wang M, et al. (2019). Resveratrol alleviates chronic "real-world" ambient particulate matter-induced lung inflammation and fibrosis by inhibiting NLRP3 inflammasome activation in mice. Ecotoxicol Environ Saf 182:109425.
   PubMed Web of Science ®Google Scholar
• Eissa MM, El-Moslemany RM, Ramadan AA, et al. (2015). Miltefosine lipid nanocapsules for single dose oral treatment of schistosomiasis mansoni: a preclinical study. PLoS One 10: e0141788.
   PubMed Web of Science ®Google Scholar
• Eldesouky LM, El-Moslemany RM, Ramadan AA, et al. (2021). Cyclosporine lipid nanocapsules as thermoresponsive gel for dry eye management: promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits. Pharmaceutics 13: 360.
   PubMed Web of Science ®Google Scholar
• Epstein Shochet G, Brook E, Bardenstein-Wald B, Shitrit D. (2020). TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling. Respir Res 21: 56.
   PubMed Web of Science ®Google Scholar
• Fan EKY, Fan J. (2018). Regulation of alveolar macrophage death in acute lung inflammation. Respir Res 19: 50.
   PubMed Web of Science ®Google Scholar
• Feng M, Zhong LX, Zhan ZY, et al. (2017). Enhanced antitumor efficacy of resveratrol-loaded nanocapsules in colon cancer cells: physicochemical and biological characterization. Eur Rev Med Pharmacol Sci 21: 375–82.
   PubMed Web of Science ®Google Scholar
• Frozza RL, Bernardi A, Hoppe JB, et al. (2013). Lipid-core nanocapsules improve the effects of resveratrol against Abeta-induced neuroinflammation. J Biomed Nanotechnol 9: 2086–104.
   PubMed Web of Science ®Google Scholar
• Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, et al. (2021). The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: from antioxidant to epigenetic therapy. Ageing Res Rev 67:101271.
   PubMed Web of Science ®Google Scholar
• Groo AC, Saulnier P, Gimel JC, et al. (2013). Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int J Nanomed 8: 4291–302.
   PubMed Web of Science ®Google Scholar
• Hamelmann E, Schwarze J, Takeda K, et al. (1997). Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156: 766–75.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. (2002). A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19: 875–80.
   PubMed Web of Science ®Google Scholar
• Honda T, Ota H, Yamazaki Y, et al. (2003). Proliferation of type II pneumocytes in the lung biopsy specimens reflecting alveolar damage. Respir Med 97: 80–5.
   PubMed Web of Science ®Google Scholar
• Hülsmann S, Khan A, Hagos L, et al. (2021). Evaluation of a mechanical lung model to test small animal whole body plethysmography. Sci Rep 11: 17099.
   PubMed Web of Science ®Google Scholar
• Humphries DC, Mills R, Dobie R, et al. (2021). Selective myeloid depletion of galectin-3 offers protection against acute and chronic lung injury. Front Pharmacol 12:715986.
   PubMed Web of Science ®Google Scholar
• Kececiler-Emir C, Ilhan-Ayisigi E, Celen-Erden C, et al. (2021). Synthesis of resveratrol loaded hybrid silica-PAMAM dendrimer nanoparticles with emphases on inducible nitric oxide synthase and cytotoxicity. Plant Foods Hum Nutr 76: 219–25.
   PubMed Web of Science ®Google Scholar
• Lan YW, Choo KB, Chen CM, et al. (2015). Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther 6: 97.
   PubMed Web of Science ®Google Scholar
• Laskin DL, Malaviya R, Laskin JD. (2019). Role of macrophages in acute lung injury and chronic fibrosis induced by pulmonary toxicants. Toxicol Sci 168: 287–301.
   PubMed Web of Science ®Google Scholar
• Li Y, Qian W, Wang D, et al. (2018). Resveratrol relieves particulate matter (mean diameter < 2.5 μm)-induced oxidative injury of lung cells through attenuation of autophagy deregulation. J Appl Toxicol 38: 1251–61.
   PubMed Web of Science ®Google Scholar
• Liu FB, Lin Q, Liu ZW. (2016). A study on the role of apoptotic human umbilical cord mesenchymal stem cells in bleomycin-induced acute lung injury in rat models. Eur Rev Med Pharmacol Sci 20: 969–82.
   PubMed Web of Science ®Google Scholar
• Meyerholz DK, Sieren JC, Beck AP, Flaherty HA. (2018). Approaches to evaluate lung inflammation in translational research. Vet Pathol 55: 42–52.
   PubMed Web of Science ®Google Scholar
• Mohseni R, ArabSadeghabadi Z, Ziamajidi N, et al. (2019). Oral administration of resveratrol-loaded solid lipid nanoparticle improves insulin resistance through targeting expression of SNARE proteins in adipose and muscle tissue in rats with type 2 diabetes. Nanoscale Res Lett 14: 227.
   PubMed Web of Science ®Google Scholar
• Mowery NT, Terzian WTH, Nelson AC. (2020). Acute lung injury. Curr Probl Surg 57: 100777.
   PubMed Web of Science ®Google Scholar
• Nile SH, Nile A, Qiu J, et al. (2020). COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev 53:66–70.
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Gilligan MM, Huang S, et al. (2020). Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev 39: 337–40.
   PubMed Web of Science ®Google Scholar
• Peltier S, Oger JM, Lagarce F, et al. (2006). Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res 23: 1243–50.
   PubMed Web of Science ®Google Scholar
• Perrone S, Tataranno ML, Buonocore G. (2012). Oxidative stress and bronchopulmonary dysplasia. J Clin Neonatol 1: 109–14.
   PubMedGoogle Scholar
• Plaza-Oliver M, Santander-Ortega MJ, Lozano MV. (2021). Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res 11: 471–97.
   PubMed Web of Science ®Google Scholar
• Qiao Q, Liu X, Yang T, et al. (2021). Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design. Acta Pharm Sin B 11: 3060–91.
   PubMed Web of Science ®Google Scholar
• Ramadan A, Lagarce F, Tessier-Marteau A, et al. (2011). Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. Int J Nanomed 6:2941–51.
   PubMed Web of Science ®Google Scholar
• Ro S, Imai R, Tamura T. (2020). Efficacy of tacrolimus for bleomycin-induced lung injury. QJM 113: 807–8.
   PubMed Web of Science ®Google Scholar
• Rodrigues KL, Souza JR, Bazilio DS, et al. (2021). Changes in the autonomic and respiratory patterns in mice submitted to short-term sustained hypoxia. Exp Physiol 106: 759–70.
   PubMed Web of Science ®Google Scholar
• Roger E, Gimel JC, Bensley C, et al. (2017). Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model. J Control Release 253:11–8.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Benoit JP. (2009). The gastrointestinal stability of lipid nanocapsules. Int J Pharm 379: 260–5.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Benoit JP. (2011). Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Eur J Pharm Biopharm 79: 181–8.
   PubMed Web of Science ®Google Scholar
• Roulet A, Armand L, Dagouassat M, et al. (2012). Intratracheally administered titanium dioxide or carbon black nanoparticles do not aggravate elastase-induced pulmonary emphysema in rats. BMC Pulm Med 12:38.
   PubMed Web of Science ®Google Scholar
• Shami GJ, Cheng D, Verhaegh P, et al. (2021). Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease. Sci Rep 11: 3319.
   PubMed Web of Science ®Google Scholar
• Sharun K, Tiwari R, Dhama J, Dhama K. (2020). Dexamethasone to combat cytokine storm in COVID-19: clinical trials and preliminary evidence. Int J Surg 82:179–81.
   PubMed Web of Science ®Google Scholar
• Shetty SK, Tiwari N, Marudamuthu AS, et al. (2017). p53 and miR-34a feedback promotes lung epithelial injury and pulmonary fibrosis. Am J Pathol 187: 1016–34.
   PubMed Web of Science ®Google Scholar
• Shieh JM, Tseng HY, Jung F, et al. (2019). Elevation of IL-6 and IL-33 levels in serum associated with lung fibrosis and skeletal muscle wasting in a bleomycin-induced lung injury mouse model. Mediators Inflamm 2019:1–12.
   Web of Science ®Google Scholar
• Solinas C, Perra L, Aiello M, et al. (2020). A critical evaluation of glucocorticoids in the management of severe COVID-19. Cytokine Growth Factor Rev 54:8–23.
   PubMed Web of Science ®Google Scholar
• Steffen L, Ruppert C, Hoymann HG, et al. (2017). Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model. Am J Physiol Lung Cell Mol Physiol 313: L313–L327.
   PubMed Web of Science ®Google Scholar
• Tian S, Xiong Y, Liu H, et al. (2020). Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 33: 1007–14.
   PubMed Web of Science ®Google Scholar
• Vannella KM, Wynn TA. (2017). Mechanisms of organ injury and repair by macrophages. Annu Rev Physiol 79:593–617.
   PubMed Web of Science ®Google Scholar
• Wang M, Long J, Zhang S, et al. (2020). Folate-targeted anticancer drug delivery via a combination strategy of a micelle complex and reducible conjugation. ACS Biomater Sci Eng 6: 1565–72.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li X, Chen H, et al. (2021). Resveratrol alleviates bleomycin-induced pulmonary fibrosis via suppressing HIF-1α and NF-κB expression. Aging (Albany NY) 13: 4605–16.
   PubMedGoogle Scholar
• Zakaria DM, Zahran NM, Arafa SAA, et al. (2021). Histological and physiological studies of the effect of bone marrow-derived mesenchymal stem cells on Bleomycin induced lung fibrosis in adult albino rats. Tissue Eng Regen Med 18: 127–41.
   PubMed Web of Science ®Google Scholar
• Zaki SM, Hussein GHA, Khalil HMA, Abd Algaleel WA. (2021). Febuxostat ameliorates methotrexate-induced lung damage. Folia Morphol (Warsz) 80: 392–402.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu K, Zeng H, et al. (2019). Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Int J Nanomed 14:6061–71.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Hao C, Li C, et al. (2018). Omentin-1 protects against bleomycin-induced acute lung injury. Mol Immunol 103:96–105.
   PubMed Web of Science ®Google Scholar
• Zivarpour P, Reiner Ž, Hallajzadeh J, Mirsafaei L. (2022). Resveratrol and cardiac fibrosis prevention and treatment. Curr Pharm Biotechnol 23: 190–200.
   PubMed Web of Science ®Google Scholar
• Zupancic S, Lavric Z, Kristl J. (2015). Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm 93:196–204.
   PubMed Web of Science ®Google Scholar